Emanuelli, A., Souleyreau, W., Chouleur, T., Boeckx, B., Pobiedonoscew, Y., Cooley, L., . . . Bikfalvi, A. Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation. Elsevier.
Chicago Style (17th ed.) CitationEmanuelli, Andrea, et al. Targeting the IL34-CSF1R Axis Improves Metastatic Renal Cell Carcinoma Therapy Outcome via Immune-vascular Crosstalk Regulation. Elsevier.
MLA (9th ed.) CitationEmanuelli, Andrea, et al. Targeting the IL34-CSF1R Axis Improves Metastatic Renal Cell Carcinoma Therapy Outcome via Immune-vascular Crosstalk Regulation. Elsevier.
Warning: These citations may not always be 100% accurate.